ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,120,986 | +826.8% | 396,339 | +798.7% | 0.02% | +1000.0% |
| Q2 2023 | $876,267 | -65.0% | 44,100 | -69.9% | 0.00% | -71.4% |
| Q1 2023 | $2,505,759 | +78.0% | 146,279 | +103.3% | 0.01% | +75.0% |
| Q4 2022 | $1,408,062 | -74.0% | 71,950 | -78.8% | 0.00% | -77.8% |
| Q3 2022 | $5,410,000 | +79.6% | 338,999 | +54.8% | 0.02% | +80.0% |
| Q2 2022 | $3,013,000 | -22.3% | 218,962 | -10.5% | 0.01% | -9.1% |
| Q1 2022 | $3,880,000 | -28.4% | 244,650 | -1.4% | 0.01% | -8.3% |
| Q4 2021 | $5,416,000 | -12.8% | 248,114 | +19.4% | 0.01% | -14.3% |
| Q3 2021 | $6,213,000 | -16.8% | 207,875 | +23.3% | 0.01% | -17.6% |
| Q2 2021 | $7,466,000 | -49.2% | 168,569 | -49.1% | 0.02% | -55.3% |
| Q1 2021 | $14,699,000 | +159.0% | 331,286 | +220.1% | 0.04% | +137.5% |
| Q4 2020 | $5,675,000 | +1609.3% | 103,480 | +613.3% | 0.02% | +1500.0% |
| Q3 2020 | $332,000 | -31.0% | 14,507 | -36.9% | 0.00% | -50.0% |
| Q2 2020 | $481,000 | – | 22,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |